Science Explorer Back to mapMap
Discussion
Company · Herzliya · Israel

ORASIS Pharmaceuticals (Israel)

orasis-pharma.comROR OpenAlex
Research works
2
▲ 194% vs 2018-21
Citations
38
15.2 per fractional work
Top-10% rate
20.4%
all institutions 10.0%
Open access
73%
world 40%
International
76%
world 18%
ORASIS Pharmaceuticals (Israel)

Not ranked overall: ORASIS Pharmaceuticals (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ORASIS Pharmaceuticals (Israel) work in?

In all years, 64% of research at ORASIS Pharmaceuticals (Israel) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (60%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (8%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 64.0% of its workMedicine: 2 fractional works · 60.0% of its workHealth Professions: 0 fractional works · 4.0% of its workLife Sciences: 1 fractional works · 32.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 12.0% of its workImmunology and Microbiology: 0 fractional works · 8.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 8.0% of its workNeuroscience: 0 fractional works · 4.0% of its workSocial Sciences: 0 fractional works · 4.0% of its workPsychology: 0 fractional works · 4.0% of its workALL ITS WORKORASISPharmaceuticals…2fractional works, all years
Life Sciences32%Health Sciences64%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine260.0%
    2. Health Professions04.0%
    1. Biochemistry, Genetics and Molecular Biology012.0%
    2. Immunology and Microbiology08.0%
    3. Pharmacology, Toxicology and Pharmaceutics08.0%
    4. Neuroscience04.0%
    1. Psychology04.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.38× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 8.16× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 10.17× its world share, 0 worksPharmacology, Toxico…Health Professions: 1.36× its world share, 0 worksHealth ProfessionsMedicine: 3.55× its world share, 1 worksMedicinePsychology: 1.18× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.2×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics10.17×0 works
  2. Immunology and Microbiology8.16×0 works
  3. Medicine3.55×1 works
  4. Biochemistry, Genetics and Molecular Biology2.38×0 works
  5. Health Professions1.36×0 works
  6. Psychology1.18×0 works

What are the most cited papers from ORASIS Pharmaceuticals (Israel)?

The most cited paper from ORASIS Pharmaceuticals (Israel) is "Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study" (Shepherd Roee Singer, Frederick J. Angulo, David L. Swerdlow et al., 2021), with 29 citations. Next come "Epidemiology of clinically significant migraine in Israel: a retrospective database study" (7) and "Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study" (7).

Most cited papers
#PaperReleasedCitations
1 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study Shepherd Roee Singer, Frederick J. Angulo, David L. Swerdlow et al. · EClinicalMedicine Open access 29 Nov 2021 29
2 Epidemiology of clinically significant migraine in Israel: a retrospective database study Alla Shifrin, Eytan Domany, Matanya Tirosh et al. · The Journal of Headache and Pain Open access 3 Feb 2025 7
3 Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study Sarah Sharman Moser, Galia Spectre, Pia Raanani et al. · Research and Practice in Thrombosis and Haemostasis Open access Apr 2022 7
4 Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical Trial Yuval Ishay, Joel Neutel, Yotam Kolben et al. · Gastro Hep Advances Open access 7 Dec 2023 3
5 Triptan Use and Potential Undertreatment in Migraine: A Retrospective Cohort Study Yael Barer, Moshe Hoshen, Sivan Gazit et al. · Journal of Clinical Medicine Open access 12 Feb 2026 2
All 9 most cited papers, with filters and sorting

Which research topics does ORASIS Pharmaceuticals (Israel) publish most on?

By volume in 2022-now: Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, Venous Thromboembolism Diagnosis and Management and Long-Term Effects of COVID-19.

Immune Cell Function and Interaction: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksVenous Thromboembolism D…0Venous Thromboembolism Diagnosis and Management: 0 fractional worksLong-Term Effects of COVID-19: 0 fractional worksBlood Coagulation and Thrombosis Mechanisms: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksCentral Venous Catheters and Hemodialysis: 0 fractional worksAllergic Rhinitis and Se…0Allergic Rhinitis and Sensitization: 0 fractional worksVirus-based gene therapy research: 0 fractional worksCAR-T cell therapy research: 0 fractional works
ImmunologyInfectious DiseasesInternal MedicineNeurology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune Cell Function and Interaction Immunology 0 works
  2. 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  3. 3 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  4. 4 Long-Term Effects of COVID-19 Neurology 0 works
  5. 5 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
  6. 6 Dermatology and Skin Diseases Dermatology 0 works
  7. 7 Central Venous Catheters and Hemodialysis Emergency Medical Services 0 works
  8. 8 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  9. 9 Virus-based gene therapy research Genetics 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.0%not open27.0%

World: 40% of research is openly available.

with international co-authors76.0%domestic only24.0%

World: 18% is written across borders.

How has ORASIS Pharmaceuticals (Israel)'s research output changed?

Output in 2022-2025 was 194% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Herzliya

All research institutions in Herzliya

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ORASIS Pharmaceuticals (Israel). Posts are plain text and can be reported.